November 28, 2024 - 06:05

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
July 4, 2026 - 16:52
DXC Technology (DXC) Stock May Be Above Fair Value After Private Cloud LaunchDXC Technology`s stock has dropped about 75 percent over the last five years, but even after that steep decline, the shares still appear overvalued based on several key financial metrics. That...
July 3, 2026 - 22:57
DXC Technology (DXC) Enters LOXO Partnership To Bring Autonomous Logistics To FleetsDXC Technology has announced a new partnership with LOXO aimed at bringing self-driving logistics technology to commercial vehicle fleets. The deal combines LOXO`s Level 4 autonomous driving...
July 3, 2026 - 13:50
Artificial Intelligence for Information Technology Operations (AIOps) for Financial Services Global Market Report 2026The global market for Artificial Intelligence for Information Technology Operations, or AIOps, in financial services is experiencing rapid expansion. This growth is fueled by the increasing...
July 2, 2026 - 18:28
Building a scholarly communityA new initiative at the Massachusetts Institute of Technology is working to deepen connections between researchers across different disciplines. The SHASS Faculty Fellows Program, run by the MIT...